APAF1 and neurodegenerative disease: This observation (pharmacological association between Ubc13 and APAF1) can be utilized in future efforts to identify potent drug leads that inhibit both targets and, therefore, by affecting two independent mechanisms in neurodegenerative diseases the potential efficacy of the multitarget therapy is enhanced.